Effect of anti-lymphocytic serum on experimental infection with Candida albicans in guinea pigs.
D000372:Agglutination Tests; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D000970:Antineoplastic Agents; D002175:Candida; D002177:Candidiasis / Q000276:immunology / Q000473:pathology; D006168:Guinea Pigs; D006652:Histological Techniques; D007106:Immune Sera / Q000494:pharmacology; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007668:Kidney / Q000473:pathology; D007962:Leukocytes / Q000187:drug effects; D008099:Liver / Q000473:pathology; D008168:Lung / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008214:Lymphocytes / Q000187:drug effects; D009206:Myocardium / Q000473:pathology; D009504:Neutrophils / Q000187:drug effects; D011018:Pneumonia, Pneumococcal / Q000276:immunology / Q000473:pathology; D011817:Rabbits; D013154:Spleen / Q000473:pathology; D013223:Statistics as Topic
D000906:Antibodies; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D007106:Immune Sera